Young Richard A 4

What Happened Richard A. Young, a director of Camp4 Therapeutics Corp (CAMP), received a derivative award on 2026-06-10 covering 28,000 shares. The Form 4 reports an acquisition for $0.00, indicating this was a grant of a stock-based award (an option or similar derivative), not a cash purchase or sale.

Key Details

• Transaction date: 2026-06-10 (Form 4 filed 2026-06-12; filing appears timely).
• Nature: Award/Grant (transaction code A); 28,000 derivative shares granted at $0.00.
• Vesting: The shares underlying the option vest in full on the earlier of the first anniversary of the grant date or the issuer’s next annual meeting, subject to continued service (per footnote).
• Post-transaction total holdings: The filing does not disclose Young’s total post-transaction beneficial ownership on this Form 4.
• No indication of immediate sale or cashless exercise in this filing.

Context This is a grant of a derivative equity award to a director—common for compensation and retention. Because it’s an award (not a market purchase or sale), it doesn’t directly signal buying or selling pressure. The vesting condition means the award converts to vested shares only if Young remains with the company through the vesting trigger.